Format

Send to

Choose Destination
See comment in PubMed Commons below
Mult Scler. 2004 Oct;10(5):596-7.

Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis.

Author information

1
Department of Neurology, Hôpital R. Salengro, CHRU of Lille, Lille, France. j-deseze@chru-lille.fr

Abstract

In order to assess the effectiveness of monthly intravenous corticosteroids in reducing childbirth-associated acute exacerbations in multiple sclerosis (MS), we compared pregnant patients followed up in our MS clinic. During the first period (1996-1998), 22 patients did not receive any treatment after delivery. During the second period (1999-2001), following the publication of the PRIMS study, 20 patients were treated monthly with 1 g of intravenous corticosteroids during the six months of the postpartum period. In both groups the relapse rate increased during the first trimester postpartum but it was higher in the untreated group (2+/-0.66 [mean+/-SD]) compared with the treated group (0.8+/-0.41) (P=0.018), suggesting a beneficial effect of monthly intravenous corticosteroids.

PMID:
15471379
DOI:
10.1191/1352458504ms1079sr
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center